ArticleBriefings in bioinformatics2026
miRSiC: a regulatory-aware machine learning framework for microRNA expression inference across bulk and single-cell transcriptomes.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
MicroRNAs (miRNAs) are key post-transcriptional regulators embedded in gene regulatory networks between upstream transcription factors (TFs) and downstream target genes (TGs), yet most computational approaches infer miRNA expression using unstructured transcriptomic features without explicitly modeling their regulatory architecture. In this study, we develop miRSiC, an interpretable machine learning framework that integrates TFs and experimentally validated TGs for regulatory-aware miRNA expression inference. miRSiC formulates prediction as miRNA-specific regression tasks and evaluates three regulatory configurations (TF-only, TG-only, and combined TF-TG) using Light Gradient Boosting Machine. Applied to The Cancer Genome Atlas (TCGA) breast cancer cohort, the integrated model achieves superior performance (mean Spearman correlation = 0.5462 across 326 miRNAs), outperforming single-layer models and demonstrating the effectiveness of incorporating both upstream and downstream regulatory signals. Feature importance analysis and regulatory network reconstruction show that selected features are enriched in biologically coherent TF-miRNA-target circuits. Prediction performance varies across breast cancer subtypes, reflecting differences in regulatory patterns and sample size. Cross-platform evaluation further reveals that models trained on bulk transcriptomes do not generalize to single-cell data due to distributional shifts and sparsity; however, domain-specific retraining partially restores performance. Together, miRSiC provides an interpretable and biologically grounded framework for miRNA expression inference, highlighting the importance of modeling regulatory context and adopting domain-aware strategies across bulk and single-cell transcriptomic data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.